Becton Dickinson Cash on Hand 2012-2026 | BDX
Becton Dickinson cash on hand from 2012 to 2026. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
- Becton Dickinson cash on hand for the quarter ending June 30, 2026 was $864M, a 5.49% increase year-over-year.
- Becton Dickinson cash on hand for 2025 was $0.859B, a 62.67% decline from 2024.
- Becton Dickinson cash on hand for 2024 was $2.301B, a 54.53% increase from 2023.
- Becton Dickinson cash on hand for 2023 was $1.489B, a 27.59% increase from 2022.
|
Becton Dickinson Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2025 | $859 |
| 2024 | $2,301 |
| 2023 | $1,489 |
| 2022 | $1,167 |
| 2021 | $2,404 |
| 2020 | $2,937 |
| 2019 | $620 |
| 2018 | $1,253 |
| 2017 | $14,200 |
| 2016 | $1,907 |
| 2015 | $1,519 |
| 2014 | $2,750 |
| 2013 | $2,608 |
| 2012 | $2,181 |
| 2011 | $1,563 |
|
Becton Dickinson Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2026-06-30 | $864 |
| 2026-03-31 | $1,018 |
| 2025-12-31 | $1,035 |
| 2025-09-30 | $785 |
| 2025-06-30 | $819 |
| 2025-03-31 | $763 |
| 2024-12-31 | $830 |
| 2024-09-30 | $2,301 |
| 2024-06-30 | $5,338 |
| 2024-03-31 | $3,221 |
| 2023-12-31 | $1,236 |
| 2023-09-30 | $1,489 |
| 2023-06-30 | $1,032 |
| 2023-03-31 | $2,074 |
| 2022-12-31 | $745 |
| 2022-09-30 | $1,167 |
| 2022-06-30 | $2,774 |
| 2022-03-31 | $3,335 |
| 2021-12-31 | $2,055 |
| 2021-09-30 | $2,404 |
| 2021-06-30 | $3,305 |
| 2021-03-31 | $3,922 |
| 2020-12-31 | $3,464 |
| 2020-09-30 | $2,937 |
| 2020-06-30 | $2,986 |
| 2020-03-31 | $2,445 |
| 2019-12-31 | $617 |
| 2019-09-30 | $620 |
| 2019-06-30 | $606 |
| 2019-03-31 | $777 |
| 2018-12-31 | $1,046 |
| 2018-09-30 | $1,253 |
| 2018-06-30 | $1,524 |
| 2018-03-31 | $1,434 |
| 2017-12-31 | $1,321 |
| 2017-09-30 | $14,200 |
| 2017-06-30 | $13,904 |
| 2017-03-31 | $911 |
| 2016-12-31 | $1,283 |
| 2016-09-30 | $1,907 |
| 2016-06-30 | $2,046 |
| 2016-03-31 | $2,022 |
| 2015-12-31 | $1,629 |
| 2015-09-30 | $1,519 |
| 2015-06-30 | $1,718 |
| 2015-03-31 | $2,129 |
| 2014-12-31 | $8,784 |
| 2014-09-30 | $2,750 |
| 2014-06-30 | $2,639 |
| 2014-03-31 | $2,626 |
| 2013-12-31 | $2,513 |
| 2013-09-30 | $2,608 |
| 2013-06-30 | $2,299 |
| 2013-03-31 | $2,421 |
| 2012-12-31 | $2,512 |
| 2012-09-30 | $2,181 |
| 2012-06-30 | $2,188 |
| 2012-03-31 | $2,112 |
| 2011-12-31 | $2,694 |
| 2011-09-30 | $1,563 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $51.228B | $21.840B |
| Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $104.880B | 22.04 |
| Cardinal Health (CAH) | United States | $54.109B | 20.66 |
| West Pharmaceutical Services (WST) | United States | $25.687B | 42.94 |
| Straumann Holding AG (SAUHY) | Switzerland | $18.592B | 0.00 |
| Align Technology (ALGN) | United States | $10.528B | 16.28 |
| Cooper (COO) | United States | $10.130B | 11.56 |
| Henry Schein (HSIC) | United States | $9.754B | 16.48 |
| Merit Medical Systems (MMSI) | United States | $5.146B | 23.48 |
| DENTSPLY SIRONA (XRAY) | United States | $1.960B | 6.87 |
| CONMED (CNMD) | United States | $1.406B | 9.82 |
| STAAR Surgical (STAA) | United States | $1.125B | 35.07 |
| Pro-Dex (PDEX) | United States | $0.214B | 19.97 |
| Lifevantage (LFVN) | United States | $0.077B | 11.04 |